PERCUTANEOUS ENDOSCOPIC GASTROSTOMY IN PATIENTS WITH AMYOTROPHIC-LATERAL-SCLEROSIS AND IMPAIRED PULMONARY-FUNCTION

被引:91
|
作者
MATHUSVLIEGEN, LMH [1 ]
LOUWERSE, LS [1 ]
MERKUS, MP [1 ]
TYTGAT, GNJ [1 ]
DEJONG, JMBV [1 ]
机构
[1] UNIV AMSTERDAM, ACAD MED CTR, DEPT NEUROL, 1105 AZ AMSTERDAM, NETHERLANDS
关键词
D O I
10.1016/S0016-5107(94)70211-X
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Amyotrophic lateral sclerosis is a rapidly progressive disease of unknown etiology resulting in tetraparalysis, dysarthria, dysphagia, and ultimately death from respiratory insufficiency. In the course of the disease, recurrent episodes of aspiration, pneumonia, dehydration, and malnutrition may necessitate nasoenteral tube placement, an inconvenient and unattractive arrangement in patients with dribbling and impaired swallowing. A percutaneous endoscopic gastrostomy seemed a better, though potentially hazardous, alternative in view of the often severely restricted pulmonary function of these patients. Therefore, we prospectively investigated the use of percutaneous endoscopic gastrostomy in 68 consecutive patients with amyotrophic lateral sclerosis. Minimum required pulmonary function was defined as forced vital capacity (FVC) of 1 L or more and CO2 gas exchange capability as pCO(2) of 45 mm Hg or less. The methodology of insertion was adapted to facilitate the early removal of gastric air. Fifty-five patients (median FVC, 1.7 L; pCO(2), 40 mm Hg) were eligible for the gastrostomy procedure, and 13 patients (median FVC, 0.8 L; pCO(2), 47 mm Hg) were not. Despite the fact that modification of the method of insertion rendered the procedure more difficult, the success rate was 89% (49/55); it was 96% (49/51) when failures related to distorted anatomy were excluded. The procedure-related mortality rate was 1.8% and the 24-hour in-hospital mortality rate was 3.6%, mainly related to respiratory insufficiency. The 30-day out-of-hospital mortality rate was 11.5%. Major complications (3.6%) consisted of a spontaneously draining cutaneous abscess in 2 cases. Peristomal redness was present in 6 cases, and 5 patients required analgesics for wound pain. Median survival (122 days) in gastrostomy-eligible patients was not different from median survival in the group that did not receive a gastrostomy (92.5 days), but in the latter group, tube-related complaints (3 out of 6 patients) and repeated episodes of choking on foods and drinks interfered with quality of life. Provided the gastrostomy placement technique minimizes air insufflation, facilitates adequate and early removal of gastric air, and avoids intravenous sedation, the method appears to be successful and safe in a subset of highly disabled patients with respiratory compromise and far-advanced neurologic disease.
引用
收藏
页码:463 / 469
页数:7
相关论文
共 50 条
  • [31] Impact of Percutaneous Endoscopic Gastrostomy (PEG) on the Evolution of Disease in Patients with Amyotrophic Lateral Sclerosis (ALS)
    Lopez-Gomez, Juan J.
    Ballesteros-Pomar, Maria D.
    Torres-Torres, Beatriz
    De la Maza, Begona
    Penacho-Lazaro, Maria A.
    Palacio-Mures, Jose M.
    Abreu-Padin, Cristina
    Sanz-Gallego, Irene
    De Luis-Roman, Daniel A.
    NUTRIENTS, 2021, 13 (08)
  • [32] Percutaneous endoscopic gastrostomy (PEG) as a procedure to improve survival of patients with amyotrophic lateral sclerosis (ALS)
    Cano, Jordi Greoles
    ATENCION PRIMARIA, 2022, 54 (04):
  • [33] Timing and impact of percutaneous endoscopic gastrostomy insertion in patients with amyotrophic lateral sclerosis: a comprehensive analysis
    Son, Bugyeong
    Lee, Jisu
    Ryu, Soorack
    Park, Yongsoon
    Kim, Seung Hyun
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [34] Outcome after percutaneous endoscopic gastrostomy in patients with bulbar and spinal amyotrophic lateral sclerosis.
    Finocchiaro, E
    Galletti, R
    Chio', A
    Rivetti, M
    Fadda, M
    De Angelis, C
    Barletti, C
    Musso, A
    Carucci, P
    Debernardi, W
    Saracco, G
    GASTROINTESTINAL ENDOSCOPY, 2000, 51 (04) : AB219 - AB219
  • [35] Percutaneous gastrostomy in amyotrophic lateral sclerosis: a review
    Castanheira, AndrE
    Swash, Michael
    De Carvalho, Mamede
    AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION, 2022, 23 (3-4) : 176 - 189
  • [36] Handling of drugs for administration by percutaneous endoscopic gastrostomy in patients with amyotrophic lateral sclerosis and enteral nutrition
    Polo, Amparo Vazquez
    Briz, Eduardo Lopez
    Andres, Jose Luis Poveda
    Costa, Juan Francisco Vazquez
    NUTRICION HOSPITALARIA, 2022, 39 (04) : 716 - 722
  • [37] Percutaneous Endoscopic Gastrostomy in the Patient with Amyotrophic Lateral Sclerosis: Risk vs Benefit?
    Procaccini, Nicholas J.
    Nemergut, Edward C.
    PRACTICAL GASTROENTEROLOGY, 2008, 32 (03) : 24 - 34
  • [38] Percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis:: Effects on nutritional status and survival
    Chiò, A
    Cucatto, A
    Terreni, AA
    Finocchiaro, E
    Da Pont, C
    Rivetti, M
    Onorati, P
    Calvo, A
    Schiffer, D
    NEUROLOGY, 1998, 50 (04) : A30 - A30
  • [39] Percutaneous Radiologic Gastrostomy in Patients With Amyotrophic Lateral Sclerosis on Noninvasive Ventilation
    Park, Jung Hyun
    Kang, Seong-Woong
    ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 2009, 90 (06): : 1026 - 1029
  • [40] Therapeutic effects of percutaneous endoscopic gastrostomy on survival in patients with amyotrophic lateral sclerosis: A meta-analysis
    Cui, Fang
    Sun, Liuqing
    Xiong, Jianmei
    Li, Jianyong
    Zhao, Yangang
    Huang, Xusheng
    PLOS ONE, 2018, 13 (02):